Andrew J Amato-Gauci
Overview
Explore the profile of Andrew J Amato-Gauci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Day M, Jacobsson S, Spiteri G, Kulishev C, Sajedi N, Woodford N, et al.
BMC Infect Dis
. 2022 Jun;
22(1):524.
PMID: 35672671
Background: The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the European Union/European Economic Area (EU/EEA). We present the...
2.
Cole M, Day M, Jacobsson S, Amato-Gauci A, Spiteri G, Unemo M
Euro Surveill
. 2022 May;
27(18).
PMID: 35514307
Because cefixime and ceftriaxone resistance in and gonorrhoea treatment failures were increasing, a response plan to control and manage multidrug-resistant (MDR-NG) in Europe was published in 2012. The three main...
3.
Sperle I, Nielsen S, Bremer V, Gassowski M, Brummer-Korvenkontio H, Bruni R, et al.
Front Public Health
. 2021 Jun;
9:568524.
PMID: 34123980
A robust estimate of the number of people with chronic hepatitis C virus (HCV) infection is essential for an appropriate public health response and for monitoring progress toward the WHO...
4.
Adlhoch C, Mook P, Lamb F, Ferland L, Melidou A, Amato-Gauci A, et al.
Euro Surveill
. 2021 Mar;
26(11).
PMID: 33739256
Between weeks 40 2020 and 8 2021, the World Health Organization European Region experienced a 99.8% reduction in sentinel influenza virus positive detections (33/25,606 tested; 0.1%) relative to an average...
5.
Mardh O, Quinten C, Amato-Gauci A, Duffell E
Infect Dis (Lond)
. 2020 Jul;
52(9):625-637.
PMID: 32644030
WHO has set target to reduce mortality attributable to hepatitis B (HBV) and hepatitis C (HCV) by 65% by 2030, with 2015 as baseline. We aimed to describe the European...
6.
Cole M, Quinten C, Jacobsson S, Day M, Amato-Gauci A, Woodford N, et al.
BMC Infect Dis
. 2019 Dec;
19(1):1040.
PMID: 31822275
Background: European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) antimicrobial resistance (AMR) data are used to inform gonorrhoea treatment guidelines; therefore the data need to be robust and representative. We assessed the...
7.
Mardh O, Quinten C, Kuchukhidze G, Seguy N, Dara M, Amato-Gauci A, et al.
Euro Surveill
. 2019 Dec;
24(48).
PMID: 31796153
Human immunodeficiency virus (HIV) transmission among women remains an issue in the WHO European Region, with nearly 50,000 women diagnosed in 2018 and over half (54%) diagnosed late. Although new...
8.
Mason L, Veldhuijzen I, Duffell E, van Ahee A, Bunge E, Amato-Gauci A, et al.
J Viral Hepat
. 2019 Jul;
26(12):1431-1453.
PMID: 31332919
An estimated 9 million individuals are chronically infected with hepatitis B virus (HBV) and hepatitis C virus (HCV) across the European Union/European Economic Area (EU/EEA), many of which are yet...
9.
Cole M, Field N, Pitt R, Amato-Gauci A, Begovac J, French P, et al.
Sex Transm Infect
. 2019 Jun;
96(2):137-142.
PMID: 31235527
Objectives: Understanding the public health impact of lymphogranuloma venereum (LGV) in Europe is hampered by inadequate diagnostics and surveillance systems in many European countries. We developed and piloted LGV surveillance...
10.
van de Laar M, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, et al.
Euro Surveill
. 2019 May;
24(19).
PMID: 31088600
BackgroundA steady increase in HIV drug resistance (HIVDR) has been demonstrated globally in individuals initiating first-line antiretroviral therapy (ART). To support effective use of ART and prevent spread of HIVDR,...